Histopathologic findings associated with APOL1 risk variants in chronic kidney disease

被引:48
|
作者
Larsen, Christopher P. [1 ]
Beggs, Marjorie L. [1 ]
Saeed, Mohammad [1 ]
Ambruzs, Josephine M. [1 ]
Cossey, L. Nicholas [1 ]
Messias, Nidia C. [1 ]
Walker, Patrick D. [1 ]
Freedman, Barry I. [2 ]
机构
[1] Nephropath, Little Rock, AR 72211 USA
[2] Wake Forest Sch Med, Winston Salem, NC USA
关键词
FOCAL SEGMENTAL GLOMERULOSCLEROSIS; STAGE RENAL-DISEASE; AFRICAN-AMERICANS; HYPERTENSIVE NEPHROSCLEROSIS; CLASSIFICATION; MORPHOLOGY; HIV;
D O I
10.1038/modpathol.2014.92
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The effects of nephropathy risk variants in the apolipoprotein L1 gene (APOL1) on renal histopathology in African Americans with arterionephrosclerosis or putative 'hypertension-associated' nephropathy are unknown. APOL1 genotype-phenotype correlations were performed in a blinded manner from renal biopsies in 196 self-reported African Americans with arterionephrosclerosis on kidney biopsy at a large national nephropathology practice. Subjects had chronic kidney disease without nephrotic syndrome. A discovery analysis compared histopathologic changes in the glomerular and tubulointerstitial compartments in 58 subjects with 2 versus 56 subjects with 0 APOL1 risk variants. Validation was performed in biopsies from 82 additional subjects with 0, 1, and 2 risk variants. Two risk variant versus zero risk variant group genotype associations and subphenotypes were assessed by chi(2) analyses. ANOVA compared means of continuous variables. In discovery analyses, significantly less obsolescent glomerulosclerosis, more (solidified and disappearing) glomerulosclerosis, more thyroidization-type tubular atrophy, and more microcystic tubular dilatation were seen in patients with two versus zero APOL1 risk alleles. Greater degrees of arteriosclerosis were present in those with zero risk alleles. Segmental glomerulosclerosis did not differ significantly between groups. Presence of two of the following discriminatory histopathologic findings from discovery, that is, <50% obsolescent glomerulosclerosis, thyroidization-type tubular atrophy, and microcystic tubular dilatation, was specific for the presence of two APOL1 risk alleles in the validation phase. African Americans with arterionephrosclerosis who possess two APOL1 risk variants more often lack obsolescent glomerulosclerosis and have greater degrees of (solidified and disappearing) glomerulosclerosis, thyroidization-type tubular atrophy, and microcystic tubular dilation than patients with fewer than two risk variants. These findings support involvement of multiple cell types in subnephrotic forms of APOL1-associated nephropathy, particularly renal tubule cells with resultant tubulointerstitial disease.
引用
收藏
页码:95 / 102
页数:8
相关论文
共 50 条
  • [21] Sequencing rare and common APOL1 coding variants to determine kidney disease risk
    Limou, Sophie
    Nelson, George W.
    Lecordier, Laurence
    An, Ping
    O'hUigin, Colm S.
    David, Victor A.
    Binns-Roemer, Elizabeth A.
    Guiblet, Wilfried M.
    Oleksyk, Taras K.
    Pays, Etienne
    Kopp, Jeffrey B.
    Winkler, Cheryl A.
    KIDNEY INTERNATIONAL, 2015, 88 (04) : 754 - 763
  • [22] APOL1 Gene Kidney Risk Variants and Cardiovascular Disease: Getting to the Heart of the Matter
    McLean, Nicholas O.
    Robinson, Todd W.
    Freedman, Barry I.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2017, 70 (02) : 281 - 289
  • [23] APOL1 Kidney Risk Variants and Cardiovascular Disease: An Individual Participant Data Meta-Analysis
    Grams, Morgan E.
    Surapaneni, Aditya
    Ballew, Shoshana H.
    Appel, Lawrence J.
    Boerwinkle, Eric
    Boulware, L. Ebony
    Chen, Teresa K.
    Coresh, Josef
    Cushman, Mary
    Divers, Jasmin
    Gutierrez, Orlando M.
    Irvin, Marguerite R.
    Ix, Joachim H.
    Kopp, Jeffrey B.
    Kuller, Lewis H.
    Langefeld, Carl D.
    Lipkowitz, Michael S.
    Mukamal, Kenneth J.
    Musani, Solomon K.
    Naik, Rakhi P.
    Pajewski, Nicholas M.
    Peralta, Carmen A.
    Tin, Adrienne
    Wassel, Christina L.
    Wilson, James G.
    Winkler, Cheryl A.
    Young, Bessie A.
    Zakai, Neil A.
    Freedman, Barry, I
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 30 (10): : 2027 - 2036
  • [24] Protein-truncating variant in APOL3 increases chronic kidney disease risk in epistasis with APOL1 risk alleles
    Zhang, David Y.
    Levin, Michael G.
    Duda, Jeffrey T.
    Landry, Latrice G.
    Witschey, Walter R.
    Damrauer, Scott M.
    Ritchie, Marylyn D.
    Rader, Daniel J.
    JCI INSIGHT, 2024, 9 (19)
  • [25] APOL1 Kidney-Risk Variants Induce Mitochondrial Fission
    Ma, Lijun
    Ainsworth, Hannah C.
    Snipes, James A.
    Murea, Mariana
    Choi, Young A.
    Langefeld, Carl D.
    Parks, John S.
    Bharadwaj, Manish S.
    Chou, Jeff W.
    Hemal, Ashok K.
    Petrovic, Snezana
    Craddock, Ann L.
    Cheng, Dongmei
    Hawkins, Gregory A.
    Miller, Lance D.
    Hicks, Pamela J.
    Saleem, Moin A.
    Divers, Jasmin
    Molina, Anthony J. A.
    Freedman, Barry, I
    KIDNEY INTERNATIONAL REPORTS, 2020, 5 (06): : 891 - 904
  • [26] Genetic variation in APOL1 and MYH9 genes is associated with chronic kidney disease among Nigerians
    Tayo, Bamidele O.
    Kramer, Holly
    Salako, Babatunde L.
    Gottesman, Omri
    McKenzie, Colin A.
    Ogunniyi, Adesola
    Bottinger, Erwin P.
    Cooper, Richard S.
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2013, 45 (02) : 485 - 494
  • [27] APOL1 Kidney Risk Alleles: Population Genetics and Disease Associations
    Limou, Sophie
    Nelson, George W.
    Kopp, Jeffrey B.
    Winkler, Cheryl A.
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2014, 21 (05) : 426 - 433
  • [28] Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
    Genovese, Giulio
    Friedman, David J.
    Ross, Michael D.
    Lecordier, Laurence
    Uzureau, Pierrick
    Freedman, Barry I.
    Bowden, Donald W.
    Langefeld, Carl D.
    Oleksyk, Taras K.
    Knob, Andrea L. Uscinski
    Bernhardy, Andrea J.
    Hicks, Pamela J.
    Nelson, George W.
    Vanhollebeke, Benoit
    Winkler, Cheryl A.
    Kopp, Jeffrey B.
    Pays, Etienne
    Pollak, Martin R.
    SCIENCE, 2010, 329 (5993) : 841 - 845
  • [29] APOL1 Variants Increase Risk for FSGS and HIVAN but Not IgA Nephropathy
    Papeta, Natalia
    Kiryluk, Krzysztof
    Patel, Ami
    Sterken, Roel
    Kacak, Nilgun
    Snyder, Holly J.
    Imus, Phil H.
    Mhatre, Anand N.
    Lawani, Anil K.
    Julian, Bruce A.
    Wyatt, Robert J.
    Novak, Jan
    Wyatt, Christina M.
    Ross, Michael J.
    Winston, Jonathan A.
    Klotman, Mary E.
    Cohen, David J.
    Appel, Gerald B.
    D'Agati, Vivette D.
    Klotman, Paul E.
    Gharavi, Ali G.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 22 (11): : 1991 - 1996
  • [30] APOL1 risk variants and the development of HIV-associated Nephropathy
    Goyal, Rohan
    Singhal, Pravin C.
    FEBS JOURNAL, 2021, 288 (19) : 5586 - 5597